课题基金 / 基金详情

Radiobiological and Molecular Biological Study of Enhancement Effect of High LET Heavy Ion Irradiation and Chemotherapeutic Agents in vitro

Radiobiological and Molecular Biological Study of Enhancement Effect of High LET Heavy Ion Irradiation and Chemotherapeutic Agents in vitro
高LET重离子照射与化疗药物体外增强作用的放射生物学和分子生物学研究
批准号:
17591292
负责人:
TAKAHASHI Takeo
金额:
$1.95万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2007

项目摘要

项目成果

TAKAHASHI Takeo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We investigate the differences between two rat yolk sac tumor cell lines with different radiosensitivities in sensitivity to high-LET heavy ion beam and in sensitizing effect and the mechanism of cisplatin and etoposide in combination with heavy-ion beam. NMT-1 (wild-type p53 cell) is a parent radiosensitive cell line and NMT-1R (mutant-type p53 cell) is a variant radioresistant cell line. The dose average LET value in the samples was 80 keV/μm. The concentration of chemotherapeutic agents required to reduce colony formation by 50% at 1-hour treatment (IC50 of etoposide) was selected for heavy ion irradiation pretreatment for each cell line. The mechanism of the enhancement effect was investigated by apoptosis and cell cycle and mechanism of DNA repair. The RBE of carbon beam was larger in mutant-type p53 cells than in wild-type p53 cells. Etoposide showed a synergistic effect in combination with carbon beam irradiation in NMT-1R cells. However, there was no enhancement effect in radiosensitive NMT-1 cells. The incidence of apoptosis, the distribution of cell cycle and the ability of DNA repair did not change between carbon beam irradiation alone and the combination of carbon beam irradiation and etoposide od cisplation in both cell lines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interaction of high-LET heavy-ion irradiation and chemotherapeutic agents on two cell lines with different radiosensitivities and different p53 status in vitro.
高 LET 重离子照射和化疗药物对体外具有不同放射敏感性和不同 p53 状态的两种细胞系的相互作用。
DOI: --
发表时间: 2006
期刊: Radiotherapy & Oncology 81
影响因子: --
作者: [Osada H, Honda N, Takahashi T, Oku S, Abe A, Watanabe W, Okada T, Ohno H, Hondo M, Nishimura K, Takahashi T, Takahashi T, Takahashi T]
通讯作者: Takahashi T
MRI Perfusion Study in Head And Neck Cancers for Early Prediction of Response to Radiotherapy: A Preliminary Study.
头颈癌 MRI 灌注研究用于早期预测放射治疗的反应:一项初步研究。
DOI: --
发表时间: 2006
期刊: Austral-Asian Journal of Cancer 5
影响因子: --
作者: [Osada H, Honda N, Takahashi T, Oku S, Abe A, Watanabe W, Okada T, Ohno H, Hondo M, Nishimura K, Takahashi T, Takahashi T]
通讯作者: Takahashi T
Aggressive multiple lung metastases from intracranial atypical meningioma
颅内非典型脑膜瘤侵袭性多发性肺转移
DOI: --
发表时间: 2005
期刊: Jpn J Tomography 32・1
影响因子: --
作者: [Hanada K, Hosono M, Takeuchi R, Komeya Y, Yoh T, Hanada K, Komeya Y, Nakada H, Takahashi T]
通讯作者: Takahashi T
DOI: --
发表时间: 2007
期刊: Ann Nucl Med 21
影响因子: --
作者: [Osada H, Honda N, Takahashi T, Oku S, Abe A, Watanabe W, OkadaT, Ohno H, Hondo M, NishimuraK]
通讯作者: NishimuraK
21
    Interaction of heavy-ion microbeam and chemotherapeutic agents in vitro
    • 批准号:
      20591504
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.41万
    • 财政年份:
      2008
    • 负责人:
      TAKAHASHI Takeo
    • 依托单位:
    Developing the National Standard of Physical Education Contents and Examining their validation
    • 批准号:
      19200045
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $29.87万
    • 财政年份:
      2007
    • 负责人:
      TAKAHASHI Takeo
    • 依托单位:
    Developing a video program of physical education classes for teacher education and examining the effects
    • 批准号:
      16300193
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.06万
    • 财政年份:
      2004
    • 负责人:
      TAKAHASHI Takeo
    • 依托单位:
    Gene therapy used by p53 of radioresistant tumor for enhancing radiosensitivity
    • 批准号:
      11670910
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.73万
    • 财政年份:
      1999
    • 负责人:
      TAKAHASHI Takeo
    • 依托单位:
    海外基金